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Until fairly recently, rehabilitation programmes 
could be considered a component of pneumology, 
possibly even of a secondary importance. Now, with 
the development of specific evaluation techniques 
and long-term care programmes, pulmonary rehabili- 
tation can be applied to patients throughout the 
course of the disease; from the earliest symptoms to 
the management of impairment secondary to end- 
stage respiratory insufficiency. Although comprehen- 
sive programmes of treatment include pulmonary 
rehabilitation, reports of the benefits are mostly from 
uncontrolled and unsupervised studies (1). Proper 
evaluation of candidates to these programmes is 
essential to success. In order to optimize the pro- 
gramme, the pulmonary rehabilitation team needs 
not only an evaluation of somatic and physiological 
issues, but also needs to account for, quantify and 
monitor variables that are important determinants of 
a patient’s quality of life (QOL). One approach to full 
account is the so-called functional approach which 
relates to impairment (the physiological deficit), dis- 
ability (total effect of impairment on the patient’s life) 
and handicap (the social disadvantages) as part of the 
comprehensive programme of care. The functional 
approach is not only useful for monitoring the 
patient’s functional status, but it enables the rehabili- 
tation team to set and achieve goals to improve the 
health-related quality of the patient’s life (2). 
Medical and Physiological Evaluation 
Objectives of the medical evaluation for respira- 
tory rehabilitation include confirming the diagnosis, 
characterizing the severity of main symptoms, and 
identifying the impact of the diseases on the patient’s 
life-style (3). The first step is an interview on the 
patient’s medical history and psychosocial problems 
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and needs (4). The patient’s medical history should 
underline the severity of the patient’s lung disease 
and identify other problems that might preclude 
participation in the programme, such as neurological 
deficits and lack of compliance to a proposed pro- 
gramme. Tests of rehabilitation effects must recog- 
nize the nature of affective factors and must be 
adjusted to suit individual patient capabilities (5). 
Laboratory data should include pulmonary func- 
tion, exercise tests, arterial blood gases, chest radio- 
graph, electrocardiogram and chemistries. Additional 
diagnostic testing can be planned as needed. 
Respiratory function tests help to characterize and 
quantify impairment resulting from the patient’s lung 
disease. Dynamic and static lung volume measure- 
ments are the most useful and can be supplemented 
with other tests such as diffusing capacity, airway 
resistance, respiratory muscle (RM) strength and 
endurance. Pulmonary function tests have some 
limitations. The degree of airflow obstruction as 
estimated by FEV, and exercise capacity do not 
correlate well in chronic obstructive pulmonary dis- 
ease (COPD) patients (6,7). Several factors such as 
pulmonary vascular disease, diffusion disorder and 
degeneralized muscle weakness may interfere, adding 
complexity to this relationship. Malnutrition, de- 
training and treatment with corticosteroids may 
contribute to muscle weakness (8-10). Furthermore, 
it has been reported that baseline lung function 
cannot predict benefit of pulmonary rehabilitation 
programmes (11). 
Assessment of RMfunction is mandatory in pre- 
scribing and evaluating the results of a pulmonary 
rehabilitation programme in conditions such as 
COPD, interstitial lung disease and neuromuscular 
disease. The simplest approach is to measure inspira- 
tory and expiratory pressure at the mouth when the 
subject performs maximal efforts against a closed 
airway (MIP and MEP, respectively), according 
to the technique described by Black and Hyatt (12). 
To obtain reproducible values, the subject needs to 
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perform several manoeuvres because of the learning 
effect (13). It is customary to measure MEP at or near 
total lung capacity (TLC) and to measure MIP at 
residual volume (RV) or functional residual capacity 
(FRC). Although there is relatively little difference 
between RV and FRC, measurement at or near FRC 
is preferable since, at this level of lung volume, 
respiratory system recoil has little or no effect on the 
pressure measured. Several reference values are avail- 
able but intra-subject variability is relevant (14). The 
best way to use this measurement is to evaluate the 
effect of a programme. 
The direct tests of inspiratory muscle (IM) endur- 
ance are based on the capacity of the IM to sustain 
high levels of pressure. The oldest test is a test of 
ventilatory endurance. Practically, the time for which 
maximal and submaximal levels of minute ventilation 
can be sustained is recorded. There is no ventilatory 
load other than the intrinsic resistive and elastic 
characteristics of the respiratory system. The level of 
ventilation that can be sustained for 15 min or longer 
is referred to as the maximum sustainable ventilatory 
capacity (MSVC). The most commonly used IM 
endurance test is based on the pressure required to 
overcome an inspiratory load. The ability to sustain 
such a breathing effort depends on the force and 
duration of IM contraction, as expressed by the 
concept of tension-time index proposed by Bellemare 
and Grassino (15). Some authors use an inspiratory 
threshold load instead of an inspiratory resistive load 
to test IM endurance. This technique is based on the 
principle that to initiate inspiration, a targeted pres- 
sure must be generated to lift a plunger and let the air 
in. Thereafter, the inspiratory pressure remains con- 
stant for the entire inspiration and the level of 
pressure is independent of inspiratory flow rate. The 
pressure required to inspire is directly proportional to 
the load. From a practical standpoint, the devices are 
of simple construction and easy to use (16). 
Although an exercise test may help in uncovering 
other co-existing diseases, it is generally necessary to 
assess patient’s exercise tolerance and to evaluate 
possible blood gas changes which can not be pre- 
dicted from the baseline lung function tests (7). The 
exercise test is generally used to establish a safe and 
appropriate prescription for subsequent training (17). 
Cardiopulmonary exercise testing has been confirmed 
to be useful in the evaluation of exercise tolerance in 
patients with dyspnoea and cardiopulmonary dis- 
eases. When compared with a clinical laboratory 
approach, cardiopulmonary exercise testing allowed 
the detection of underestimated circulatory compo- 
nent causing exercise limitation (18). Graded exercise 
testing has been shown to be useful in diagnosing 
patients with chronic unexplained dyspnoea. How- 
ever, it was not sensitive in distinguishing a cardiac 
disease from deconditioning (19). Variables measured 
and/or monitored during testing should include 
workload, heart rate, electrocardiogram, arterial 
oxygenation and symptoms. Other measurements, 
such as expired gas analysis, to calculate variables 
such as oxygen consumption (PO,), may be per- 
formed depending on the interest and expertise of the 
referring physician, laboratory personnel and pro- 
gramme staff. Assessment of exercise is best made 
using the type of exercise that will be employed in 
training (e.g. treadmill testing for a walking exercise 
training programme). However, results from one type 
of exercise test can be translated to similar forms of 
exercise (20). Although regular bicycle exercise was 
unfamiliar and generated the greatest lactate 
response, the VO, peak did not differ between cycle 
and treadmill exercise in COPD patients (21). 
Measuring the distance covered during a walking 
test is considered a simple and reproducible way to 
determine exercise tolerance in patients with chronic 
lung disease. The initially proposed test involved the 
distance covered with a 12 min walk (12 mwd, 12 min 
walking distance). It was shown that the distance 
walked was related to VO, peak. The test has been 
shortened progressively to the most used 6 mwd and, 
more recently, a ‘shuttle’ 2 mwd test has been 
proposed (22-24). 
Blood gas sampling during exercise adds a signifi- 
cant degree of complexity to testing. Non-invasive 
techniques, such as cutaneous oximetry of arterial 
oxygen saturation, are useful for continuous moni- 
toring, but should not be relied on for precise assess- 
ment of arterial oxygenation because of their limited 
accuracy (25). 
Dyspnoea and Quality of Life 
Traditionally, physicians have used pulmonary 
function tests both to establish a diagnosis, such as 
airflow obstruction, and to follow the course of the 
lung disease. The approach is problematic because 
the severity of dyspnoea, which is usually the 
patient’s main complaint, is only weakly related to 
physiologic lung function (26). Furthermore, clinical 
ratings of dyspnoea and pulmonary function tests are 
separate factors or quantities that independently 
characterize the condition of patients with COPD 
(27). Dyspnoea ratings influence and predict general 
health status to a greater extent than do physiological 
measurements in symptomatic patients with COPD. 
As suggested by Mahler, ‘a shift in focus from the 
pathophysiology of disease to assessment and relief 
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of symptoms may provide more meaningful benefits 
for the individual patients in terms of quality of life’. 
This consideration requires that care givers use avail- 
able methods of measurement in clinical practice to 
quantify symptoms and the overall health status (28). 
Dyspnoea, RM strength and physical functioning 
declined over 2 yr in a cohort study of patients with 
symptomatic COPD, suggesting that these patients 
may adapt to deterioration in dyspnoea and physi- 
ologic function by adjusting their lifestyle to maintain 
role and social functioning, mental health and health 
perceptions, and minimize pain (29). Both psycho- 
social methods and clinical scales have been used 
to assess breathlessness. Clinical methods used to 
measure dyspnoea have depended primarily on the 
magnitude of the exertional task that evokes breath- 
lessness. Fletcher’s scale (30) and the British Medical 
Research Council (BMRC) scale (31) related to the 
magnitude of the task, but there is little provision for 
the associated effort. A separate disadvantage of 
these scales is that functional impairment, a conse- 
quence of dyspnoea, is not considered. The problems 
can be circumvented by using the visual analogue 
technique, which consists of a measured line with 
descriptive phrases at various points along the line 
(32). The visual analogue scale (VAS) has been used 
for an oxygen cost diagram in which daily activities 
are ranked along the line in proportion to their 
associated oxygen cost (33). The Borg scale offers a 
quantitative approach to estimate dyspnoea sensa- 
tion with given exercise loads; the changes in the 
dyspnoea sensation with peak exercise can be 
assessed objectively (34). A close linear relationship 
between the Borg scale and oxygen consumption 
during exercise in healthy and disease states was 
found. All these methods provide information when 
serial measurements are performed within a single 
patient, but these methods would not be appropriate 
for comparing dyspnoea in different patients nor for 
comparing the conditions of groups of patients. 
Recently, a new instrument to include the compo- 
nents of functional impairment and magnitude of 
effort in addition to the magnitude of task for 
dyspnoea evaluation (Baseline Dyspnoea Index: 
BDI) has been proposed by Mahler (35). The BDI 
is a multidimensional instrument which has proven 
to be valid and reliable in patients with chronic 
respiratory disease (2629). 
The majority of patients with chronic respiratory 
disease seek medical evaluation when difficulty in 
breathing interferes with their ability to perform 
various daily activities and/or adversely affects the 
quality of lifr. The QOL of an individual is strongly 
influenced by factors that health care does not affect 
directly. Consequently, many researchers use the 
more restrictive term ‘Health-related quality of life’ 
(HRQL) to mean the quality of life as it is affected by 
health status. In general, HRQL questionnaires 
measure the impact of an individual’s health on 
his/her ability to perform and enjoy the activities of 
daily life. HRQL instruments vary form disease- 
specific measures of a single symptom (i.e. dyspnoea) 
to a generic global assessment of many facets which 
may include emotional functioning, social role func- 
tioning activities of daily living, and ability to enjoy 
activities. HRQL measures are able to provide 
adequate and often excellent reproducibility. How- 
ever, physiological measures such as pulmonary func- 
tion and exercise tolerance do not correlate strongly 
with measures of HRQL (36). There are generic and 
disease-specific instruments that have been used 
extensively in patients with COPD (37). The generic 
HRQL instrument which has been used most exten- 
sively in patients with COPD is the ‘Sickness Impact 
Profile’ (SIP) (38). The ‘Nottingham Health Profile’ is 
a reproducible and valid instrument in the assessment 
of chronic diseases (39). Among the disease-specific 
HRQL instruments, the ‘Chronic Respiratory Dis- 
ease Questionnaire’ (CRQ) developed by Guyatt (40) 
was shown to be reproducible, valid and more 
responsive than other measures of dyspnoea. The ‘St. 
George’s Respiratory Questionnaire’ is divided into 
three components: symptoms, activity and impact on 
daily life (35). In a comparison with SIP, it was 
shown to be twice as responsive as the generic 
instrument. The CRQ was used by Wijkstra et al. (41) 
to show that rehabilitation at home for 3 months 
followed by once monthly physiotherapy sessions 
improved QOL over 18 months, although the change 
in QOL was not associated with a change in exercise 
tolerance. Other psychosocial measures have been 
proposed and used in randomized clinical trial of 
effects of pulmonary rehabilitation in COPD patients 
(42,43). 
Occupational Evaluation 
Occupational therapy aims to restore and maxi- 
mize independence, prevent associated disability and 
maintain health. An occupational therapy assessment 
includes an interview with the subject, observation of 
functional performance, and the administration and 
interpretation of specific tests. Areas that are assessed 
are the following: self care, home and community 
skills, vocation, leisure interests, upper extremity 
muscle strength, range of motion, endurance, coordi- 
nation, physiologic responses to daily activities, psy- 
chosocial status, and cognitive and behavioural 
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problems related to function. To perform these 
evaluations, the occupational therapist must utilize 
many tools and techniques. An assessment of the 
upper extremity function can be done with an arm 
cranking ergometer, which allows an appropriate and 
easily available isolated task of testing submaximal 
and maximal cardiorespiratory function and of train- 
ing. Objective parameters monitored routinely as 
part of the functional task evaluations include 
measurement of the rate of perceived exertion and 
dyspnoea heart rate response, respiratory rate, VO, 
and oxygen saturation (44). 
Recently, new functional rehabilitation techniques 
have been introduced. Simulated work testing can be 
used by rehabilitation specialists to evaluate the 
individual functional ability to perform home, work 
and leisure activities. This type of testing is typically 
accomplished by having the individual perform a 
specified task using the actual tools and equipment 
at a work station set up in the laboratory. Work 
simulator devices are available commercially. 
Simulation of daily activities with task-specific tools 
has been well tolerated by elderly patients and has 
been shown to improve physical work capacity. 
Selection of a functional task for performance should 
be done after reviewing information collected from 
the subject. It is important to consider activities that 
the patient must be able to manage as part of their 
basic self care, or to consider specific activities the 
subject has a strong desire to perform successfully. 
The advantages of such techniques include the avail- 
ability of mechanical parameters monitored by the 
dynamometer (work exerted, power output, strength, 
mechanical fatigue, number of repetitions per time), 
and the possibility to perform strength or endurance 
tests with the actual tools used during the simulation. 
It is important to remember that before a subject is 
discharged from the rehabilitation programme, the 
results of the evaluations should be well documented. 
Quantitative indicators of physical capacity and 
tolerable work loads could be obtained by adopting 
these ‘functional techniques’ with work simulators 
and metabolic analysers. 
Nutritional Status 
Interactions of nutritional status and lung disease 
have only been the focus of research interest in the 
recent past. The problem of obesity and its implica- 
tions for RM function have been greatly overlooked. 
Optimal nutritional status should help to maximize 
the patient’s state of health, RM function and overall 
sense of well being, and could possibly improve 
disease outcome. It is generally acknowledged that a 
substantial proportion of patients with COPD are 
malnourished and that malnutrition contributes to 
the deterioration in the clinical condition. There is a 
large body of literature on nutritional assessment 
which is poorly standardized. This is caused by the 
fact that malnutrition is not well defined and most 
of the measures used can be influenced by a chronic 
negative energy balance. As a result, in Western 
medical practice, the terms ‘undernutrition’ or 
‘malnutrition’ are indiscriminately used whether the 
clinical condition results from lack of the food or 
from diseases. It may, therefore, be more appropriate 
not to call patients undernourished but rather 
depleted. The association between malnutrition and 
COPD has been recognized for many years. A sig- 
nificant percentage of patients with advanced COPD 
lose weight and muscle mass, and this process also 
affects the RM. Factors related to nutritional status 
are considered as an independent influence on the 
course of COPD and, in a previous study of the 
authors’ group, patients with a reduced percentage of 
ideal body weight (%IBW) were more likely to need 
ICU admission (45). 
The calculation of % IBW by comparing measured 
body weight to a standard has been a traditional 
method. Anthropometric parameters may also be 
useful in defining the prognosis of the disease, even 
if not its severity (46). Weight standards are an 
incomplete assessment of nutritional status because 
they do not detail variations in specific body 
components. Serial measurements to determine 
percent of usual body weight are useful to reference 
the individual to himself. Schols et al. (10) advocate 
the use of measures that reflect functions like the 
fat-free mass. Fat-free mass is a better indicator of 
body mass depletion than body weight and, there- 
fore, it may have consequences for planning the 
rehabilitative strategies. These authors found that 
depletion of fat-free mass may occur in normal- 
weight COPD patients undergoing rehabilitative pro- 
grammes, and exhibiting a physical impairment to an 
even greater degree than underweight patients with 
relative preservation of fat-free mass. Lean body 
mass (LBM) measurement would be a useful out- 
come parameter; its determination involves the use of 
anthropometric measurements as assessed by the size 
of skinfold, skeletal breadth, and circumference 
at various body sites. An alternative approach to 
estimate LBM is bioelectrical impedance analysis. 
Biochemical assessment of various body fluids has 
been advocated as a marker of nutritional status; 
these markers include albumin, pre-albumin, trans- 
ferrin and retinol-binding protein, lymphocyte count 
(for assessment of immunocompetance) and urine 
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metabolites. Visceral proteins are considered to 
reflect the severity of injury and prognosis in critically 
ill hospitalized patients, but they often do not 
accurately reflect nutritional status or adequacy of 
nutritional support (47). Other methods to assess 
nutritional status rely on delayed cutaneous 
hypersensitivity response which are decreased or 
completely suppressed in malnutrition. 
Psychological Evaluation 
In patients with COPD, in addition to progressive 
physical disability, high levels of depression and 
anxiety, and impaired performance on tests of 
memory and concentration have been found. The 
clinical syndromes of depression and anxiety, in turn, 
further reinforce the patient’s social isolation and 
physical inactivity (48). Standardized neuropsycho- 
logical tests of memory, concentration, psychomotor 
speed, emotional state and cognitive performance 
have been used to evaluate functional status and the 
effect of rehabilitation programmes (49). One of the 
most used psychological tests is the Trail Making 
Test, sensitive to changes in brain function. The Digit 
Symbol subtest of the Wechsler Adult Intelligence 
Scale is a timed test of psychomotor performance 
which has been shown to decline with age. The 
Digit Span subtest of the WAIS-R provides a good 
indicator of concentration and short-term memory, 
both of which may be impaired in COPD patients 
(SO). 
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